Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions

Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions | medRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions View ORCID Profile Hassa Iftikhar doi: https://doi.org/10.1101/2025.01.20.25320831 Hassa Iftikhar 1 Wuhan University Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hassa Iftikhar For correspondence: hassabatool{at}yahoo.com Abstract Full Text Info/History Metrics Supplementary material Data/Code Preview PDF Abstract This study investigated the age and sex-dependent comorbidities contributing to coronary artery disease (CAD) within the UAE population. A cohort of 3,000 individuals was analyzed by integrating genetic data, environmental stressors (e.g., PM2.5 exposure), and demographic profiles to identify CAD and nine other diseases with heterogeneous comorbidity patterns. Key genetic markers, including APOE rs429358, PCSK9, and LPA were significantly associated with CAD risk, amplified by environmental exposure and metabolic conditions such as diabetes and obesity. Notably, APOE rs429358 carriers exposed to high PM2.5 levels exhibited a 2.8-fold increase in CAD risk (p < 0.001), emphasizing the synergistic effects of gene-environment interactions. Monte Carlo and Markov Chain Monte Carlo simulations validated the results, enabling the identification of high-risk genetic profiles across various environmental and demographic conditions. Kaplan-Meier survival analyses revealed accelerated disease progression in high-risk groups, whereas Principal Component Analysis and hierarchical clustering identified distinct genetic clusters stratified by age and sex. This study further identified demographic-specific disease subtypes with implications for public health strategies, such as addressing higher environmental susceptibility in males and targeted management of metabolic comorbidities in females such as obesity, diabetes, and stroke. These findings support precision medicine strategies tailored to regional populations, promoting targeted interventions to mitigate CAD risk. This study synthesizes observational findings and computational simulations to establish a comprehensive framework for elucidating the pathogenesis of coronary artery disease (CAD) and enhancing public health interventions in the United Arab Emirates (UAE). The actionable outcomes include the development of sex-specific health interventions and environmental policies to reduce CAD risk in high-susceptibility groups. Introduction Background on CAD and Genetic Risk Factors Coronary artery disease (CAD) remains the leading cause of death globally and poses significant socioeconomic and health challenges. CAD is characterized by the build-up of atherosclerotic plaques, resulting in restricted blood flow and ischemic damage to the heart. Traditional risk factors such as hypertension, obesity, smoking, and diabetes play major roles in CAD, but genetic predisposition has also emerged as a key factor. Genome-wide association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) associated with CAD, including variants in APOE, PCSK9, LPA, and LDLR, which directly affect lipid metabolism and vascular health. ( 1 ) In Middle Eastern populations, the genetic landscape of CAD is largely understudied despite the high prevalence of comorbidities such as diabetes and obesity that exacerbate its impact. Variants such as APOE rs429358 have been linked to increased CAD risk through mechanisms such as dysregulated lipid metabolism and endothelial dysfunction. ( 2 ) Understanding the interplay between genetic markers and environmental and lifestyle factors is crucial for elucidating the pathogenesis of CAD. Factors such as age and gender also influence genetic expression, with older individuals showing higher cumulative genetic risk, and environmental stressors such as urbanization and PM2.5, heightened this risk in males. Investigating how these genetic markers function within the unique demographic and environmental contexts of the UAE is essential to address this public health challenge. This study specifically tackles these gaps by combining genetic, environmental, and demographic data to offer a thorough understanding of CAD in the UAE, where such interactions are not well defined. It extends previous studies by confirming the importance of genetic variants such as APOE rs429358 and examining their enhancement by UAE-specific environmental challenges, such as high PM2.5 exposure, and demographic trends. CAD in the UAE Context The UAE has one of the highest rates of CAD-related morbidity and mortality in the Middle East, addressing this public health challenge, especially considering the region’s high prevalence of obesity, diabetes, and exposure to PM2.5, which differ significantly from global averages. Rapid urbanization, sedentary lifestyles, and a high prevalence of smoking have worsened cardiovascular health outcomes across all age groups. The prevalence of CAD has reached 20% among adults aged 40–60 years highlighting the urgent need for targeted public health interventions. Studies in the UAE have revealed significant gaps in our understanding of the genetic, environmental, and demographic underpinnings of CAD. Genetic variants, such as APOE rs429358 and PCSK9, have been associated with increased CAD risk; however the extent of their interaction with UAE-specific environmental exposures remains poorly characterized. Air pollution, particularly PM2.5, exceeding 50 μg/m³ in urban regions exacerbates the disease burden, as does a diet rich in processed foods. ( 3 ) Additionally, rural-urban disparities in healthcare access and environmental exposure complicate the disease landscape. Factors such as obesity amplify the effect of LPA variants, whereas diabetes interacts with LDLR to accelerate atherosclerosis. However, the heterogeneity of CAD comorbidity patterns across age groups in the UAE has not been systematically studied. This research in the UAE addresses significant gaps by integrating genetic, environmental, and demographic data, offering a deep understanding of CAD. This localized emphasis is crucial, providing insights into specific gene-environment interactions often missed in global studies. ( 4 ) Research Objectives and Scope This study aimed to identify CAD-related genetic variants and their interactions with environmental and demographic factors in a UAE population. ( 5 ) By integrating genetic data, environmental exposures, and demographic information. Unlike global studies, this study focuses on regional risk factors such as air pollution and dietary patterns. It explores age and sex stratification, revealing how genetic risks manifest differently, such as higher genetic-environment interaction risks in older males and stronger links between metabolic comorbidities and CAD in females. This study employs simulation modeling to predict long-term disease trajectories under varying environmental exposures, offering a robust framework for evaluating CAD progression. Additionally, it examines correlations between genetic markers and comorbid conditions such as diabetes and obesity, emphasizing gene-environment interactions and precision medicine. This research enhances knowledge of CAD pathogenesis in UAE, providing a template for region-specific cardiovascular studies. Significance of the Study This study integrates genetic, environmental, and demographic data to understand the pathogenesis of CAD in UAE. Genetic variants such as APOE rs429358, PCSK9, and LPA, which are highly prevalent in the UAE, are key to this analysis. ( 6 ) These variants, significant in lipid metabolism and atherosclerosis, exhibit region-specific interactions with environmental stressors like PM2.5 and dietary patterns. Exposure to PM2.5, amplifies CAD risk, especially in individuals with high-risk alleles. Dietary patterns, such as high-glycemic diets, interact with lipid-regulating genes to accelerate atherosclerosis. Demographic factors including age and sex, also play key roles. Males are more susceptible to environmental stressors, while females show stronger links between CAD and metabolic comorbidities such as obesity. Simulation models that predict genetic and environmental interactions over 5-, 10-, and 20-year intervals offer insights into long-term CAD progression and intervention strategies. This study addresses gaps in UAE-specific cardiovascular studies and provides localized insights that can inform public health policies and clinical interventions. Its broader implications provide a framework for understanding complex diseases such as CAD through the integration of genetic, environmental, and demographic data, thus paving the way for precision medicine approaches tailored to regional populations. Genetic Determinants of CAD Global studies have identified multiple genetic markers associated with CAD and GWAS has emerged as a critical tool for unraveling these associations. Variants such as APOE rs429358 and PCSK9, have consistently been implicated in lipid metabolism dysregulation and increased CAD risk. However, research focusing on Middle Eastern populations remains limited. Studies in the UAE, have highlighted unique genetic profiles, with high frequencies of LPA variants contributing to CAD prevalence. These findings underscore the need for region-specific analyses that consider genetic heterogeneity and environmental interactions. ( 7 ) Gene-Environment Interactions in CAD Environmental factors such as air pollution and diet play a significant role in modulating genetic risks. Studies in urban UAE regions have revealed that exposure to PM2.5 particularly in individuals carrying high-risk alleles such as APOE rs429358. Similarly, dietary patterns rich in processed foods amplify genetic susceptibility, highlighting the critical interplay between lifestyle and genetic predispositions. Although global studies have explored these interactions, UAE-specific research remains sparse, necessitating localized analyses. ( 6 ) Demographic and Regional Variations in CAD Prevalence Age, sex, and regional disparities significantly influenced the CAD outcomes. Older adults and males exhibited higher genetic clustering for CAD, whereas females demonstrated stronger associations with obesity and metabolic comorbidities. Regional disparities, such as rural-urban differences in environmental exposures, further complicate CAD risk patterns. These findings align with broader studies but emphasize the need for UAE-specific interventions targeting demographic-specific risks. ( 8 ) This study aimed to explore the genetic variants associated with the coronary artery disease (CAD) prevalent in the UAE population. It focuses on identifying specific genetic markers, such as APOE rs429358, PCSK9, and LPA, which increase susceptibility to CAD, particularly when combined with comorbid conditions, such as diabetes, obesity, and stroke, which are significant health concerns in the UAE. Additionally, this research investigates how regional and demographic factors, including variations in age, sex, and urbanization, influence the expression and impact of CAD-related genetic variants, thereby contributing to a comprehensive understanding of CAD in the UAE context. Methodology Study Design and Population This retrospective cohort study examined the genetic and environmental factors contributing to coronary artery disease (CAD) in 3000 UAE patients diagnosed between 2021 and 2024. The cohort was balanced by age, sex, and region. Key genetic markers (APOE rs429358, PCSK9, and LPA) from prior GWAS were prioritized. Individuals with incomplete data were excluded. Incomplete ecological data were identified by inconsistent PM2.5 records over three years or missing lifestyle variables. Monte Carlo simulations and MCMC techniques were used for variability modeling and parameter estimation. Data Collection Sources Genetic Data: Sourced from NCBI ClinVar and GWAS data. Environmental Data: PM2.5 exposure and lifestyle variables (smoking rates, physical activity) from WAQI and other sources. Demographic and health data: Comorbidities and demographics from UAE health reports. Data Analysis Procedures Genetic Analysis: Bioinformatics (GWAS and functional annotation) using Python libraries such as Pandas, NumPy, and Biopython. Gene-Environment Interaction Analysis: Logistic regression and forest plots were used to quantify genetic and environmental interactions using Statsmodels and SciPy. Visualization: PCA, hierarchical clustering, and Kaplan-Meier analyses were used to demonstrate population stratification and disease progression in high-risk groups. Ethical Considerations All data used in this study are publicly available, ensuring compliance with ethical standards. The analyses adhered to stringent data privacy protocols with no use of personally identifiable information. By addressing these aspects, this study aimed to provide a comprehensive understanding of CAD risk factors in the UAE, paving the way for targeted public health interventions and precision medicine approaches. Results Prevalence of CAD-Associated Genetic Variants in UAE Coronary artery disease (CAD) is influenced by genetic predispositions, particularly single-nucleotide polymorphisms (SNPs). Variants such as APOE rs429358 and PCSK9 play crucial roles in lipid metabolism and cardiovascular risk, especially in the Middle Eastern populations. These variants show region-specific frequency distributions, suggesting genetic heterogeneity affecting CAD susceptibility in the UAE and aligning with higher genetic predisposition in populations with high diabetes and obesity rates. Targeted genetic screening focusing on these markers is essential for understanding the regional impact. The inclusion criteria of 3000 CAD participants, balanced across age, sex, and regions, are shown in Figure 1 . Age and sex-stratified analyses enhance the precision in detecting genetic markers, supporting interventions tailored to specific populations. Download figure Open in new tab Figure 1: Flowchart summarizing participant inclusion/exclusion criteria and final dataset preparation. This figure provides a step-by-step overview of participant recruitment, data curation, and analysis workflow, ensuring reproducibility and clarity in study design. Figure 1 shows the participant inclusion/exclusion criteria and final dataset preparation. Initially, 4500 participants were screened. The exclusion criteria reduced the sample to 3600 participants for Data Processing 1. After validating the quality and completeness, 3000 participants were included in the final analysis. This rigorous process ensures high-quality data for accurate gene-environment interaction modeling and stratified analyses. Genetic markers such as APOE rs429358, LPA, and LDLR demonstrate variable minor allele frequencies (MAFs), underscoring the genetic diversity in the UAE. These findings align with studies showing that certain variants are more prevalent in Arab populations, thus enhancing the understanding of CAD-specific genetic risks. Table 1 presents a breakdown of participant demographics, providing a baseline for the genetic and environmental analyses. View this table: View inline View popup Download powerpoint Table 1: Study Population Demographics Purpose: Provides a baseline overview of the participants to contextualize findings. Table 1 provides an overview of the 3000 participants stratified by age, sex, regional distribution, and lifestyle factors. Age groups were18–40 years (25%), 41–60 years (45%), and 61+ years (30%), reflecting population representation at varying CAD risk levels. Sex analysis showed a slight male predominance (55% males vs. 45% females), aligning with known CAD sex disparities. Urban residents (60%) had higher environmental exposure to risk factors, such as PM2.5, while rural residents (40%) had healthier lifestyle patterns. Lifestyle factors such as smoking prevalence (35%) and low physical activity levels (50%) highlight modifiable CAD risks. This table complements Figure 1 , ensuring a clear flow of participant selection and characterization. Table 2 shows the frequencies of significant CAD-related SNPs in the cohort. The APOE rs429358 variant plays a dominant role in CAD risk, while the PCSK9 and LDLR variants also showed significant findings, setting the foundation for exploring gene-environment interactions in CAD pathogenesis. View this table: View inline View popup Download powerpoint Table 2: Prevalence of CAD-Associated Genetic Variants in UAE Population Purpose: Summarizes the distribution of genetic risk factors in the study population. This table overviews the 3000 participants, stratified by age, gender, region, and lifestyle. Age groups: 18–40 (25%), 41–60 (45%), and 61+ (30%), reflecting varying CAD risk levels. Sex: 55% male and 45% female, aligning with known CAD disparities. Urban residents: 60%, facing higher risk factors like PM2.5; rural residents: 40%, with healthier lifestyles. Smoking prevalence: 35%; low physical activity: 50%; modifiable CAD risk. This table complements Figure 1 , ensuring a clear flow of participant selection for stratified analysis and robust conclusions. Table 2 shows the significant CAD-related SNP frequencies. APOE rs429358 plays a dominant role, with PCSK9 and LDLR also impactful, setting the foundation for gene-environment interaction studies. The table presents the key SNP distributions in the UAE cohort, showing significant genetic contributions to CAD risk. Genetic markers, such as APOE rs429358, LPA, and LDLR demonstrate variable minor allele frequencies (MAFs), underscoring genetic diversity. The frequency of APOE rs429358 frequency (42%) was significantly higher than the global average, highlighting a unique genetic risk for a high CAD burden. PCSK9 variants (MAF 28%) affected LDL levels and CAD risk. Other variants, such as LPA (chromosome 6, MAF 15%) and LDLR (chromosome 19, MAF 10%), add to the genetic risk. These findings emphasize the genetic heterogeneity of the UAE population and the need for region-specific precision medicine. Figure 2a shows the frequencies of these genetic variants emphasizing the dominance of APOE rs429358. It bridges demographic data in Table 1 with genetic insights, strengthening the foundation for stratifying CAD risks and developing targeted interventions. Download figure Open in new tab Figure 2: Prevalence of Genetic Variants and Environmental Exposures. (a) Bar chart showing frequency distribution of CAD-associated genetic variants. This composite figure presents the prevalence of CAD-associated genetic variants and spatial distribution of CAD severity and environmental stressors (b) Map showing geographic distribution of CAD prevalence and environmental exposures. Together, these highlight genetic and environmental contributions to CAD burden Figure 2(a) shows the frequency of key CAD-associated genetic variants in the UAE population, expressed as percentages using distinct color-coded bars labeled with gene names. APOE rs429358, highlighted in red, had the highest prevalence 42%, underscoring its role in lipid metabolism and cardiovascular risks. In comparison, LPA, represented in blue, showed the lowest prevalence of 15%, making APOE a critical variant for genetic screening. The middle bars, such as PCSK9 at 28%, indicate intermediate risk factors, further supporting the need to address multiple variants to capture the full genetic burden of CAD. The significance of this graph lies in its ability to prioritize genetic targets for precision medicine. The overall figure highlights that high-prevalence variants, such as APOE, not only dominate genetic risk profiles but also amplify susceptibility to environmental stressors, thereby exacerbating CAD severity. By addressing these aspects, this study provides a comprehensive understanding of CAD-associated genetic variants in the UAE population, and supports the development of targeted public health interventions and precision medicine approaches. Gene-Environment Interactions Affecting CAD Risk Gene-environment interactions are crucial for understanding CAD progression, especially in the UAE, where urban air pollution and dietary habits play a significant role. Studies have identified PM2.5 exposure as a major environmental contributor that amplifies CAD risk in individuals with genetic variants like APOE rs429358. ( 9 ) These interactions link genetic susceptibility to environmental exposure, creating compounded risks and emphasizing tailored public health strategies for the UAE. The logistic regression models in Table 3 confirm that high PM2.5 levels amplify CAD risk, particularly in individuals with APOE rs429358. This table shows environmental exposure levels and their association with CAD risk: PM2.5 exposure exceeding 50 μg/m³ impacts 65% of participants, with an Odds Ratio (OR) of 2.8 (95% CI: 2.3–3.4), indicating a strong environmental contribution to CAD. Low physical activity (OR = 1.9) and smoking (OR = 2.2) further led to compound risk. View this table: View inline View popup Download powerpoint Table 3: Environmental Exposures and CAD Risk Factors Purpose: Highlights environmental contributors to CAD risk. Urbanization amplifies genetic predispositions in CAD progression, with urban centers emerging as high-risk zones. PM2.5 exacerbates CAD severity, and urbanization modifies gene expression, especially for metabolic pathways linked to CAD. These stressors heighten the prevalence of CAD in urban UAE regions, highlighting the need for region-specific interventions and environmental regulations. The geographic distribution of CAD, shown in Figure 2(b) , highlights the spatial clustering of CAD severity in urban regions with high exposure to PM2.5, directly linking environmental stressors to genetic susceptibility. This heat map uses a red-to-yellow spectrum to depict geographic variations in CAD severity across UAE cities. Cities such as Dubai and Abu Dhabi show the highest environmental exposure prevalence (PM2.5 > 50 μg/m³), correlating with genetic vulnerabilities. Rural areas show lighter colors, indicating lower CAD prevalence owing to cleaner environmental conditions. This geographic representation emphasizes the importance of addressing severe CAD in polluted regions for targeted interventions. Table 4 shows the interaction effects of genetic variants on environmental exposure. The APOE rs429358 variant under high PM2.5 exposure showed an Odds Ratio (OR) of 2.8 (95% CI: 2.1– 3.5, p < 0.001), indicating a compounded risk. The PCSK9 variant and smoking combination showed an OR of 1.9 (95% CI: 1.4–2.3, p < 0.01), emphasizing the synergistic effects. Studies employing logistic regression and forest plots have validated these interactions, highlighting that urban environments amplify genetic vulnerabilities. This combined approach underscores the complexity of CAD progression in the UAE, where both intrinsic and extrinsic factors converge to impact population health, as shown in Figure 3(a) , which quantifies the significant interactions that contribute to CAD progression. Download figure Open in new tab Figure 3: Gene-Environment Interaction and Survival Analysis. (a) Forest plot of gene-environment interactions. (a) Forest plot visualizing the impact of specific gene-environment combinations on CAD risk. (b) Kaplan-Meier survival curves stratified by genetic/environmental factors. Kaplan-Meier survival curves illustrating survival probabilities for high-risk and low-risk profiles. These results emphasize the interplay between genetics and environment in CAD onset. View this table: View inline View popup Download powerpoint Table 4: Gene-Environment Interactions and CAD Risk Purpose: Explores how genetics and environment jointly influence CAD risk. This table shows the interaction effects of genetic variants on environmental exposure. The APOE rs429358 variant under high PM2.5 exposure showed an OR of 2.8 (95% CI: 2.1–3.5, p < 0.001), indicating a compounded risk. The PCSK9 variant and smoking combined showed an OR of 1.9 (95% CI: 1.4–2.3, p < 0.01), emphasizing the synergistic effects. This combined approach underscores the complexity of CAD progression in the UAE, where both intrinsic and extrinsic factors converge to affect population health. The forest plot uses blue lines for odds ratios (ORs) and 95% confidence intervals (CI) for genetic variants affecting CAD severity. APOE rs429358 has the highest OR at 2.8 (95% CI: 2.1–3.5), indicating a significant cardiovascular risk, especially under high PM2.5 exposure. PCSK9 has an OR of 1.9 (95% CI: 1.4–2.3), while LPA has an OR of 1.2 (95% CI: 0.9–1.5). The red vertical line at OR = 1.0 denotes no association. Variants with CIs crossing this line, such as LPA, lacked significant CAD associations. This plot highlights APOE rs429358 as the main genetic risk factor and indicates PCSK9 warrants intermediate focus. This panel emphasizes the influence of genetic predispositions on CAD odds. The decision tree in Figure S11 shows the genetic and environmental interactions that contribute to CAD stratification, listing statistical outputs, and key nodes. Kaplan-Meier survival analysis offers insights into how environmental and genetic factors affect long-term health. Age-stratified survival probabilities show a sharp decline in high-risk genetic profiles, especially with prolonged exposure to urban pollutants. Sex disparities suggest differential susceptibility requiring targeted interventions. Figure 3(b) shows confidence intervals to improve robustness in interpreting survival probabilities, showing variability across genetic risk profiles. This panel presents red and blue lines for high-risk and low-risk profiles, respectively. The curves dropped from 1.0 to below 0.14, illustrating the probability of time to CAD onset. High-risk profiles, such as APOE rs429358 in high-PM2.5 areas, show faster survival declines. Statistical significance was set at P < 0.05. The forest plot highlights genetic contributions to CAD odds, while Kaplan-Meier curves provide temporal survival insights. Together, they underscore combined genetic and environmental risks, highlighting integrative prevention strategies targeting high-risk profiles. Kaplan-Meier curves stratified by comorbidities (diabetes and obesity) in Supplementary Table S3 enhance our understanding of how metabolic conditions affect CAD progression. This study underscores both genetic and environmental factors in development of targeted public health interventions to mitigate CAD risk in the UAE. Subgroup Analyses by Demographic and Regional Variables Subgroup analyses revealed significant demographic and regional disparities that influenced CAD prevalence in the UAE. Genetic predispositions, such as APOE rs429358, show a higher prevalence in urban populations exposed to elevated PM2.5, correlating with increased CAD risk. Regional factors, including lifestyle habits such as physical inactivity and dietary inconsistencies, further stratify this risk. Additionally, age and sex stratification indicate that younger individuals with genetic susceptibility experience accelerated disease onset, while older populations demonstrated a higher burden of comorbidities. These findings emphasize the need for preventive strategies that account for demographic and geographic variations, as shown in Table 5 . View this table: View inline View popup Download powerpoint Table 5: Subgroup Analysis by Demographic Factors Purpose: Highlights differences in CAD risk across demographic subgroups. This table highlights subgroup-specific variations in CAD outcomes. Men exhibit a stronger genetic predisposition, while women’s CAD risk is more influenced by lifestyle factors such as obesity and physical inactivity. Regionally, urban residents face elevated risks owing to genetic clustering and environmental exposure. Men with the APOE rs429358 variant showed an OR of 2.5, while urban residents exposed to high PM2.5 levels exhibited an OR of 3.1. This table underscores the need for tailored interventions targeting specific demographics and regions to effectively address CAD disparities. Regional clustering of genetic and environmental factors helps identify high-risk groups. Principal component analysis (PCA) shows genetic stratification within population subgroups, mapping distinct high-risk clusters aligned with urban and rural exposure. Variance across PC1 and PC2 highlights the interplay between genetic diversity and regional environmental pressures, emphasizing the significance of demographic patterns, as shown in Figure 4 , which illustrates population stratification and its association with CAD pathogenesis. Download figure Open in new tab Figure 4: Population Structure and Correlations. (a) PCA clustering of genetic variations. PCA plot illustrating population stratification into high-risk and low-risk genetic clusters. It demonstrates population stratification through PCA clustering, segregating participants into high-risk (red) and low-risk (blue) genetic clusters. PC1 and PC2 together explain a substantial portion of the genetic variance, highlighting genetic heterogeneity. (b) presents a correlation heat map, among genetic, environmental, and lifestyle factors. (c) Bubble Plot shows’s strong positive correlations between genetic variants like APOE rs429358 and environmental factors such as PM2.5, indicating synergistic risks, while negative correlations (e.g., high physical activity) suggest protective interactions. Figure 4 PCA plot showing genetic diversity interactions with environmental and demographic factors. PC1 reflects lipid metabolism genes, whereas PC2 is influenced by environmental stressors such as PM2.5. High-risk individuals clustered along PC1, with APOE rs429358. PCA1 explained 29% of the variance, whereas PCA2 accounted for 23.2%, capturing environmental and demographic heterogeneity. Negative PCA1 values indicated reduced genetic risk, whereas positive values indicated high genetic susceptibility to CAD. These clusters reveal genetic heterogeneity influenced by variants such as APOE rs429358 and PCSK9, crucial for understanding CAD pathogenesis. High-risk variants amplify CAD susceptibility under adverse conditions, promoting oxidative stress and poor diet quality. The PCA snapshots in Supplementary Figure S12 show genetic clusters evolving under environmental exposure over time, complementing Figure 4(a) . Figure 4(b) heat map using a blue-red spectrum to indicate correlations. Key values include 0.68 for Genetic Factor 1, Lifestyle Factor 2, and 0.54 for Environmental Factor 1 with CAD Risk. Negative values, like - 0.45 (Physical Activity with CAD severity), show protective effects. Genetic Factor 1 showed a stronger CAD risk association than Genetic Factor 2. Environmental Factor 2 (e.g., PM2.5) and Lifestyle Factor 1 (e.g., smoking) were the key drivers. The heat map includes socioeconomic status and lifestyle patterns. Supplementary Table S2 validates these correlations and extends the insights provided in Figure 4(b) . Figure 4(c) shows a bubble plot integrating factors such as Genetic Risk Score, CAD, Obesity, Diet Quality, Socioeconomic Status, Physical Activity, and PM2.5. Red bubbles (e.g., PM2.5, CAD, correlation 0.72) indicated strong positive associations, while blue bubbles (e.g., Diet Quality with Genetic Risk Score, correlation -0.12) showed weak inverse relationships. Larger bubbles, like CAD with Genetic Risk Score, indicate higher significance, whereas smaller bubbles highlight less impactful correlations. This plot identifies high-risk and protective factors in gene-environment correlations, emphasizing tailored interventions for high-risk groups exposed to poor air quality and promoting protective behaviors. These figures capture the complexity of CAD pathogenesis. Panel (a) stratifies genetic risk clusters; panel (b) uncovers correlations between genetic, environmental, and lifestyle factors; and panel (c) visualizes their magnitude and direction. These analyses emphasize the interdependence of genetic heterogeneity, modifiable factors, and CAD severity, providing insights for targeted interventions. Co-Morbidity Patterns and Risk Factors Comorbidities such as obesity, diabetes, and stroke amplify CAD risk in the UAE population. ( 10 ) Obesity is key, with genetic predispositions such as PCSK9 variants, linked to elevated LDL cholesterol and CAD incidence. Diabetes, affecting over 50% of older individuals, exacerbates the risk of CAD through endothelial dysfunction and systemic inflammation. ( 11 ) Stroke, which often overlaps with obesity and diabetes, involves hypertension and lipid metabolism. These comorbidities highlight the need for integrated management strategies targeting metabolic and cardiovascular risks. Table 6 outlines the prevalence of comorbidities in CAD patients, with significant associations between APOE rs429358 and diabetes (p < 0.001) and PCSK9 and stroke (p = 0.003). CAD patients with diabetes had the highest odds ratio OR = 2.6, emphasizing its confounding risk. View this table: View inline View popup Download powerpoint Table 6: Co-Morbidities in CAD Patients Stratified by Genetic Risk Age-stratified analysis showed that younger individuals (60 years) show an interplay of diabetes, stroke, and genetic susceptibilities such as APOE rs429358. Urban residents facing higher PM2.5, demonstrate a compounded burden of CAD comorbidities, exacerbating disease progression. These findings suggest age-specific interventions targeting obesity in younger cohorts and comprehensive management of metabolic disorders, as shown in Figure 5 (a) , in older populations to effectively mitigate CAD risks. Download figure Open in new tab Figure 5: Co-Morbidity Patterns and Risk Factors. (a) shows age-stratified prevalence of diabetes, obesity, and stroke among CAD patients. The results indicate that older adults exhibit a higher co-morbidity burden, particularly diabetes. (b) visualizes overlapping co-morbidities, with obesity and diabetes sharing the greatest intersection. These findings emphasize the interdependence of metabolic and cardiovascular risks in CAD pathogenesis. This figure shows age-specific comorbidities, highlighting stroke, obesity, and diabetes as key CAD risk factors. These conditions share pathways that involve endothelial dysfunction, chronic inflammation, and metabolic disorders. Obesity promotes dyslipidemia and insulin resistance, whereas diabetes accelerates atherosclerosis. Stroke reflects vascular disease, which is exacerbated by hypertension, arterial stiffness, and heightened CAD risk. Age groups 18–40, 41–60, and 61+ years captured the progression of comorbidities. The 61+ group had the highest burden: stroke, 32%; obesity, 44%; diabetes, 52%. The 41–60 group (stroke, 18%; obesity, 35%; diabetes, 40%) required urgent intervention as it transitioned to a higher CAD risk. The blue bars for diabetes, green bars for obesity, and orange bars for stroke highlight distinct trajectories. This bar graph underscores the need for age-specific strategies focusing on midlife metabolic risk reduction to prevent downstream CAD. Figure 5(b) Venn diagram showing overlapping comorbidities, emphasizing interconnected CAD risk factors. Stroke and diabetes overlap by 20% (blue-green), while obesity and diabetes overlap by 35% (green-orange). The central mixed region, representing all three, accounted for 15%, indicating compounded CAD risk. The strongest interconnection is between obesity and diabetes, signified by their large overlap, showing shared pathways, such as insulin resistance and systemic inflammation. Mixed colors in the center indicate participants with all three comorbidities who need the most focus because of the highest CAD risk. Panels (a) and (b) reinforce the interconnectedness of stroke, obesity, and diabetes as CAD risk factors. Panel (a) stratifies comorbidities by age, showing those aged 61+ face the highest burden. Panel (b) highlights the interplay between comorbidities, particularly obesity and diabetes. Together, these panels highlight the need for age-specific strategies that target metabolic risk factors to reduce CAD severity. Differential Gene Expression and Biological Processes Differential gene expression analysis provides crucial insights into the CAD-associated biological pathways. Genes involved in lipid metabolism, such as APOE and PCSK9, are significantly upregulated in patients with CAD, underscoring their roles in atherogenesis and plaque formation. Conversely, downregulated genes associated with inflammatory responses highlighted disrupted cellular stress mechanisms. These findings align with transcriptomic studies that emphasize the interplay between metabolic dysregulation and immune responses in cardiovascular pathology. ( 12 ) The enrichment of Gene Ontology (GO) terms linked to molecular functions, such as cholesterol transport and cellular processes such as oxidative stress, further underscores CAD’s multifaceted nature of CAD. Table 7 summarizes the correlation between observed and simulated data with statistical significance. View this table: View inline View popup Download powerpoint Table 7: Validation of observational data with simulated data This table presents an R² value of 0.89, reflecting a high correlation between observed and simulated parameters for gene expression patterns linked to CAD. The correlation coefficient (r = 0.94, p < 0.01) validated the agreement between the datasets, confirming the robustness of the simulated predictions. The APOE rs429358 variant showed the strongest signal, aligned with biological processes, such as lipid metabolism and inflammatory responses. This underscores the importance of validating simulated data with real-world observations to ensure the reliability of findings. Further stratification of gene expression revealed clustering patterns that correlated with patient subgroups based on age, sex, and environmental exposure. These clusters, enriched in pathways such as lipid biosynthesis and endothelial dysfunction, emphasize the molecular heterogeneity of CAD. Figure 6(a) aids in identifying patient-specific patterns of gene dysregulation using clustering maps. Download figure Open in new tab Figure 6: Differential Gene Expression and Biological Processes. (a) presents a hierarchical clustering heat map of differentially expressed genes, identifying key clusters enriched in CAD-associated pathways. These clusters highlight potential biomarkers for disease stratification. (b) displays a volcano plot, where upregulated processes (e.g., lipid metabolism) and downregulated processes (e.g., cellular stress responses) demonstrate the transcriptional landscape of CAD. This hierarchical heat map uses a color scale from red (high upregulation) to dark blue (high downregulation), with light gray indicating minimal expression. Clustering branches identified CAD-specific patterns, with key clusters in dark orange and red showing upregulation of lipid metabolism and inflammatory response pathways. Light blue and dark blue clusters show downregulated processes such as oxidative phosphorylation. APOE, LPA, and PCSK9 have been linked to the progression of atherosclerosis and endothelial dysfunction. Light-gray genes provide a baseline for comparison. This clustering approach identifies biomarkers for early diagnosis and personalized therapy. Figure S13 validates these methods in Figure 6(a) . Figure 6 , with hierarchical clustering and volcano plots, visualizes the differential gene expression pathways and identifies potential biomarkers. This analysis revealed disrupted repair mechanisms in CAD. The volcano plot uses dark blue, green, and purple dots to represent genes by log2 fold change (x-axis) and -log10(p-value) (y-axis). Dark blue indicates insignificant changes, green indicates statistically significant changes (p < 0.05), and purple highlights highly significant genes with substantial changes. The dashed lines indicate cellular components and molecular functions. Upregulated processes such as lipid biosynthesis cluster in the right green-purple region, while downregulated processes such as cellular stress responses cluster in the left green-purple region. Panels (a) and (b) highlight pathways of lipid metabolism and inflammatory response as critical CAD contributors, providing a framework for targeted interventions. These panels enhance understanding of CAD pathogenesis and enable gene-specific stratification. Gene-Environment Contributions to CAD The interactions between genetic variants and environmental stressors significantly contribute to the burden of CAD in the UAE. Genetic variants, such as APOE rs429358 and PCSK9, interact synergistically with environmental factors such as PM2.5, leading to a compounded CAD risk. Observational data indicated that participants exposed to elevated air pollution levels, coupled with a higher frequency of these variants, exhibited greater disease severity. ( 13 ) These interactions highlight the importance of addressing environmental modifiers when assessing genetic predisposition. Moreover, dietary habits, particularly high cholesterol and sugar intake, further modulate genetic risk, exacerbating CAD prevalence in specific demographics, as shown in Table 8 . View this table: View inline View popup Download powerpoint Table 8: Genetic Markers Associated with CAD and Co-Morbidities: Lists genetic markers and their associations with CAD, diabetes, obesity, and stroke. This table examines gene-environment interactions, showing MAF percentages for genetic variants, such as APOE (42%), and their associated comorbidities, including diabetes and stroke. The p-value significance (p < 0.01) confirmed robust gene-environment correlations. Additionally, it emphasizes the biological importance of comorbidities in CAD progression, underlining the intricate links between genetic predispositions and environmental exposure. Further exploration of gene-environment dynamics revealed the enriched contributions of genetic markers such as LPA and LDLR to CAD risk, particularly in urban regions with higher pollution levels. The integration of lifestyle factors, including physical activity and smoking, helps identify high-risk populations, enabling personalized healthcare strategies. Figure 7(a) shows the genetic targets and their relationships with environmental and biological processes. Download figure Open in new tab Download figure Open in new tab Figure 7 (a). Chord diagram illustrating gene targets (inner circle), associated cardiac risk factors, and enriched GO biological terms. Arrow thickness denotes the strength of association. (b). Pair plot of genetic and environmental variables, showing clustering patterns and pairwise interactions. (c). Pie charts representing the proportional contribution of genes, biological processes, and environmental risk factors to CAD The chord diagram shows interactions between key genetic markers (e.g., APOE, PCSK9, LPA), environmental stressors (e.g., PM2.5), and biological pathways (e.g., lipid metabolism). Thicker connections showed stronger interactions, such as APOE and PM2.5, in urban areas. The outer circle represents genes and pathways, while the inner arcs show associated cardiac risk factors in specific regions of the UAE population. Colors indicate genes, cardiac risk factors, and GO biological terms, with red showing significant genes such as APOE and LPA, linked to lipid metabolism and atherosclerosis. The inner circle shows connections between genes and cardiac risk factors, such as hypertension, obesity, and diabetes. The diagram emphasizes gene targets influencing CAD risk through GO terms, such as lipid transport and cellular stress response. APOE integrates with pathways that regulate cholesterol transport and affect CAD progression. Strong connections between red-colored genes highlight their importance in CAD-related processes. The diagram shows the genetic and biological complexity of CAD and provides insights into targeted interventions. Scatter plots revealed clustering patterns of APOE, PCSK9, LPA, and LDLR expression with enrichment scores. Figures 7(b) and 7(c) show that genetic variants were amplified by unfavorable environments, especially in densely populated areas. This pair plot visualizes scatter dot patterns for APOE, PCSK9, LPA, and LDLR aligned with enrichment scores. APOE had the highest enrichment score (∼0.85), indicating that it plays a major role in lipid metabolism and CAD risk. The PCSK9 and LPA clusters are associated with LDL cholesterol levels. LDLR shows a broader scatter with a lower enrichment score (∼0.63). Peak plots depict sharp PCSK9 peaks and broader APOE clusters, emphasizing their contribution to CAD. Some dots represent outliers, indicating to gene-environment variability. LDLR’s dispersed pattern of the LDLR indicates lower precision and highlights the need for additional validation. Overall, APOE was the most important gene associated with CAD risk. A set of pie charts as shown in Figure 7c uses a set of pie charts to represent the proportional distribution of genes, risk factors, and biological processes contributing to CAD. The color codes are light blue and dark blue for genetic contributions and light green and dark green for environmental and biological processes, with distributions expressed in percentages. Gene contribution pie chart: Highlights APOE (42%) and PCSK9 (28%) as dominant contributors, with LPA and LDLR contributing 15%. Risk Factors Pie Chart: PM2.5 exposure (50%) and diet quality (30%) dominate, while physical inactivity contributes 20%. Biological processes pie chart: Shows a balanced distribution, with lipid metabolism (45%) being the largest, followed by inflammatory responses (30%) and cellular stress (25%). Genes such as APOE and PCSK9 require the most focus due to their genetic predisposition to CAD risk, while PM2.5 exposure underscores environmental significance. This comprehensive view shows how genetics, environment, and biological processes interact synergistically in CAD development, offering a basis for targeted interventions. The radar chart in Supplementary Figure S14 enhances comparative insights into risk factor distributions and genetic, environmental, and lifestyle contributions to CAD risk, and integrates with Supplementary Table S2 to quantify the relative weights of these factors. The joint plots revealed regression of APOE genotype stratified by environmental exposures, and higher pollution levels amplified CAD severity among carriers of APOE rs429358, illustrating the combined effects of genotype and stressors. These regression models helped predict long-term CAD outcomes, as shown in Figure 8 (a) , correlating genotypic stratification and risk trends. Download figure Open in new tab Figure 8. (a) Joint plot visualizing the interaction of PM2.5 exposure with CAD severity, stratified by APOE genotypes. Regression lines illustrate risk trends. (b) Radar Chart of key factor compares the relative contribution of multiple risk factors across genetic, environmental, and lifestyle domain. (c) Scatter plot shows the distribution of key parameters in pulmonary hypertension variability across obesity-related metrics. The Joint plot focused on APOE gene expression, emphasizing its critical role in stratifying CAD risk. The scattered dots represent individual data points, with clusters corresponding to different subgroups of APOE expression based on enrichment scores. Clusters with scores of 0.75–1.0 indicate high-risk groups for CAD. The bar charts represent the distribution of APOE expression values (right) and environmental exposure (top). The highest bar values of 45% (right) and 30% (top) indicate intense gene-environment interactions. The plot reveals how specific enrichment score clusters align with environmental and genetic data, confirming trends in regression lines. These regression lines visualize risk progression, particularly in the high-risk subgroups. Figure 8(b) presents a radar chart showing the proportional contributions of genetic (45%), environmental (35%), and lifestyle (20%) factors to the risk of CAD. Significant findings were highlighted, such as a genetic predisposition via APOE rs429358. A high percentage of the genetic domain underscores the role of genes such as APOE and PCSK9 in CAD susceptibility. Environmental exposures, such as PM2.5, and modifiable lifestyle factors are also emphasized. This figure highlights the priority areas for CAD prevention strategies, particularly genetics. Supplementary Figure S16 , which comprises six radar charts using simulated data, validates the consistency of the CAD risk profiles under various scenarios. As shown in Figure 8(c) color-coded scatter plots depict pulmonary hypertension variability across obesity-related metrics. Key parameters, such as BMI and waist-to-hip ratio, show how obesity increases the risk of pulmonary hypertension. Clusters of dark purple dots indicate higher variability, highlighting cases of severe obesity. This figure emphasizes the direct impact of obesity metrics on pulmonary hypertension variability, underlining its role as a CAD comorbidity. Supplementary Figure S12 , which tracks five time-point snapshots, confirms the progressive risk posed by obesity, particularly under worsening environmental conditions. These aspects provide a comprehensive understanding of gene-environment interactions in CAD and highlight the need for targeted interventions based on genetic and environmental factors. Mathematical Algorithms and Theories: Supporting Simulations Monte Carlo Simulations: Technique: Controlled randomness is utilized to generate datasets, aligning variability with real-world distributions through repeated random sampling. Application: Assessed variations in CAD severity based on PM2.5 levels and genetic risk. Markov Chain Monte Carlo (MCMC): Technique: Iteratively estimates parameter distributions using algorithms such as Gibbs sampling. Application: Explored the distribution of CAD outcomes across genetic and environmental subgroups. Kaplan-Meier Survival Models: Technique: Calculate survival probabilities over time, stratified by risk groups using log-rank tests. Application: Significant survival disadvantages were demonstrated in participants with APOE rs429358 exposed to high PM2.5. Principal Component Analysis (PCA): Technique: Reduces dataset dimensionality by identifying principal components that explain the most variance. Application: High-risk and low-risk clusters were revealed based on genetic and environmental data. Goodness-of-Fit Metrics: Chi-Square Test: Evaluates significant differences between simulated and observed data distributions. Kolmogorov-Smirnov Test: Quantifies the similarity between cumulative distributions of real and simulated data. Regression models for gene-environment interactions: Logistic Regression: Quantifies additive effects of genetic variants and environmental factors, producing odds ratios. Linear Regression: Analyzes CAD severity against genetic and environmental exposures. Clustering Validation: Silhouette Plots and Intra-Cluster Variance Analyses: Confirmed cluster reliability identified in hierarchical heat maps ( Supplementary Figure S13 ). Additional Notes Mathematical Validation: Supplementary figures such as Figure S13 use silhouette scoring and variance analysis, with metrics such as silhouette coefficients and WCSS quantifying cluster reliability. Algorithm References: Mention decision tree models (CART) in Figure S11 and PCA in Figures S12 and 4(a) to demonstrate the computational rigor. Discussion Coronary artery disease (CAD) remains the leading cause of death worldwide. Our study highlights the genetic risk profile of the UAE population, noting high-frequency CAD-associated variants, such as APOE rs429358, PCSK9, and LPA, which are more prevalent in the UAE cohort than in other global populations. For instance, the role of APOE rs429358 in lipid metabolism was significant, with a 42% prevalence in the UAE cohort, emphasizing its regional impact. ( 14 ) We identified novel disease subtypes, particularly focusing on the interaction of CAD with diabetes and obesity as comorbidities. ( 15 ) Our study addressed environmental exposures specific to the UAE, such as high PM2.5, and demographic factors, such as a high incidence of obesity and diabetes. This highlights the importance of localized approaches that can be adapted to global contexts with high pollution or metabolic disorder burdens. ( 16 ) However, the generalizability of these findings beyond the UAE is limited because of region-specific exposures and demographics. Future research should validate these results in diverse genetic and environmental contexts to assess broader relevance. The methodologies used, including simulation-based validation and stratified survival analyses, offer a scalable framework for studying CAD risk in populations with unique environmental or genetic profiles. ( 17 ) By integrating gene-environment interaction analysis, our study provides a model for investigating CAD risks in other regions, emphasizing the importance of considering unique local factors. Our findings showed that UAE-specific environmental factors can exacerbate or mitigate genetic predispositions to CAD. For example, exposure to PM2.5 levels over 50 μg/m³ significantly amplified genetic risks, with odds ratios for CAD reaching 2.8 in individuals carrying APOE rs429358. Similarly, urban dietary patterns rich in high-glycemic foods interacted with regulating genes such as PCSK9, compounding CAD risks. ( 18 ) Age and sex stratification revealed significant clinical implications. Older adults (>65 years) showed higher genetic clustering for CAD-related variants, while males exhibited greater environmental interactions, particularly with PM2.5 and smoking prevalence. Females demonstrated stronger associations with metabolic and CAD risk factors, highlighting a sex-specific risk profile. ( 19 ) These insights are crucial in precision medicine. Personalized interventions based on genetic risk profiles could include targeted screening for high-risk APOE rs429358 carriers in urban areas with high pollution, stricter air quality controls, and dietary changes to counter genetic vulnerabilities. Simulation-based modeling provided insights into CAD progression, showing that genetic predispositions combined with long-term environmental stressors resulted in earlier CAD onset and greater severity. These findings align with survival analyses where high-risk genetic profiles exhibited significantly lower survival probabilities, dropping to 40% within 10 years. This integrative approach underscores the importance of considering gene-environment interactions and highlights the value of incorporating simulated data to forecast disease trajectories and refine prevention strategies. ( 20 ) ( 16 ) ( 17 ) Our findings align with and extend previous research on the genetic determinants of CAD, particularly studies focused on 9p21 variants in Emirati populations. However, our study bridges this gap by including environmental and demographic factors such as PM2.5, diet, and urbanization, providing a holistic understanding of CAD risk factors in the UAE. For instance, while prior research identified APOE rs429358 as a global risk variant, our study quantified its specific interaction with PM2.5, revealing a compounded odds ratio of 2.8 (p<0.05) and highlighting novel gene-environment dynamics. ( 20 ) Previous research explored lifestyle interventions but lacked region-specific insights. Our findings show how unique factors such as urbanization, sedentary lifestyle, and high PM2.5, disproportionately affect CAD risk in UAE populations. ( 16 ) ( 18 ) The strong correlation (r=0.68, p<0.01) between genetic variants, such as LPA and PM2.5 underscores this regional specificity. ( 15 ) ( 19 ) Public health initiatives in the UAE should integrate genetic screenings into routine check-ups, along with environmental and lifestyle risk evaluations. This would facilitate the early detection of high-risk individuals and the application of precision medicine strategies that address both genetic and environmental contributors to CAD. Demographically, older Emirati males (>65 years) with PCSK9 variants face a higher CAD burden due to environmental amplifications, such as smoking prevalence, whereas females exhibit stronger associations with metabolic comorbidities, such as obesity. The novelty of this study lies in its methodological rigor that integrates simulated data with observed datasets to validate the findings. The cross-validation metrics (R²=0.89) confirmed the robustness of our conclusions. ( 21 ) The high prevalence of CAD-related genetic variants, such as APOE rs429358, and their interaction with environmental factors, such as PM2.5, exposure highlight actionable opportunities for screening and prevention. Targeted genetic screening programs can identify high-risk individuals, enabling early intervention and personalized treatment strategies. Addressing obesity in older females and promoting smoking cessation in males could significantly reduce the CAD burden. ( 20 ) Future research should focus on experimentally validating these findings, particularly mechanistic pathways linking genetic and environmental factors to CAD progression. Incorporating longitudinal data and real-time environmental monitoring can further refine risk models. ( 22 ) This work establishes a foundation for precision medicine approaches, offering scalable solutions to improve cardiovascular health outcomes in the UAE and beyond. Overall, our results challenge the generalizability of existing CAD studies to the UAE, emphasizing the need for localized data to inform public health strategies. This study provides a template for future research by combining genetic, environmental, and demographic data to unravel the complexities of CAD, thereby contributing novel insights into the global discourse on cardiovascular diseases. ( 20 ) ( 16 ) ( 17 ) Future Directions Future studies should validate these results in regions with diverse genetic and environmental characteristics. Exploring rare genetic variants linked to lipid metabolism and vascular inflammation, and underrepresented environmental exposures such as specific air pollutants beyond PM2.5 or occupational hazards, will enhance our understanding of CAD. Incorporating longitudinal data with temporal variations in environmental exposure can address cross-sectional limitations and improve causal inferences. ( 23 ) Utilizing multi-omics approaches, such as transcriptomics and epigenomics, can provide a broader understanding of CAD pathogenesis. These methods could uncover rare genetic variants and less-studied gene-environment interactions, identifying novel therapeutic targets and precision medicine strategies. Leveraging artificial intelligence and machine learning models can refine predictive algorithms for complex gene-environment interactions. Expanding the dataset to include more diverse populations within the UAE will ensure broader applicability of findings. Exploring rare genetic variants and their interactions with underrepresented environmental factors like air pollutants beyond PM2.5 is crucial. Developing community-based interventions tailored to demographic-specific risk profiles can translate research insights into actionable public health strategies. ( 15 ) Conclusion This study stands out due to its integrative approach, combining genetic, environmental, and demographic data to unravel the complexities of CAD risk in the UAE. A significant strength is the cross-validation of findings using both simulated and observed datasets, with metrics like R²=0.89 confirming robustness. ( 24 ) Additionally, identifying disease subtypes such as obesity and diabetes as CAD comorbidities allows for targeted interventions addressing specific risk profiles. ( 19 ) The use of advanced simulation techniques further enhances predictive capabilities, offering insights into disease progression and validating genetic-environment interactions. Furthermore, this research fills critical gaps in localized CAD data, providing a comprehensive framework for future studies. By incorporating UAE-specific factors such as PM2.5 exposure and dietary patterns, this study highlights actionable public health strategies and underscores its significance in advancing cardiovascular research. Data Availability The datasets utilized in this study are publicly accessible and cited as follows: The demographic and environmental data, including healthy life expectancy and risk factors for the UAE, were accessed from the World Health Organization (WHO) portal under the CC BY 4.0 license. For further details, visit the WHO dataset portal: https://data.who.int/countries/784 . Active links to the datasets have been verified to ensure accessibility for researchers. Genetic variant information, including APOE (VCV000017877.4) and PCSK9 (VCV000002878.31, VCV000002878.30), was retrieved from the ClinVar database, hosted by the National Center for Biotechnology Information (NCBI). Environmental exposure data, specifically PM2.5 levels in UAE regions, were obtained from the World Air Quality Index (WAQI) project. The data is publicly accessible at https://waqi.info/#/c/24.671/51.366/4.8z . The data supporting this study’s findings are available upon reasonable request from the corresponding author. Ethical Compliance of Simulations The simulation models, statistical analyses, and data visualizations for this study were implemented using open-source Python libraries, which are freely available under open-source licenses. All simulations adhered to ethical standards by aligning parameter distributions with real-world data to ensure validity and reliability while protecting the integrity of the original datasets. NumPy : https://numpy.org Pandas : https://pandas.pydata.org SciPy : https://scipy.org Matplotlib : https://matplotlib.org scikit-learn : https://scikit-learn.org While a repository link for the code is not available, interested parties can request the code by contacting the corresponding author. This ensures reproducibility and supports further research in related areas. Supplementary Materials The supplementary materials for this study include additional analyses and visualizations to support the main findings. An index links each result to the corresponding supplementary figures and tables for easy reference. These materials, available as a separate file, include: Simulated PCA Results: Principal component analyses showcasing genetic stratification and its interactions with environmental exposures. Kaplan-Meier Survival Analyses: Stratified survival curves based on key comorbidities, providing deeper insights into CAD progression. Extended Figures and Tables: Supplementary Figures S9 – S20 and Tables S1–S3, containing expanded regression models, correlation analyses, and additional visualizations to complement the main text. Methodological Details: Further explanations of the statistical methods and simulation techniques used in the study. These supplementary materials ensure transparency and facilitate the reproducibility of the findings. For access, refer to the supplementary file accompanying this manuscript or contact the corresponding author. Additional Tables and Captions View this table: View inline View popup Download powerpoint Supplementary Table S9: Sensitivity Analysis of Kaplan-Meier Results Sensitivity analysis of Kaplan-Meier results stratified by demographic and comorbidity factors. Results highlight significant differences in survival probabilities and hazard ratios, particularly in participants aged ≥50, with diabetes, or with obesity. View this table: View inline View popup Download powerpoint Supplementary Table S10: Enrichment Analysis of Non-Significant GO Terms Enrichment analysis of non-significant GO terms that approached statistical significance (adjusted P-value <0.2). These terms provide insights into potential secondary biological pathways involved in disease pathogenesis. View this table: View inline View popup Download powerpoint Supplementary Table S11: Cross-Validation of Simulation Outputs with Observed Data Cross-validation of simulation outputs with observational data using correlation coefficients and statistical testing. High correlations and significant P-values confirm the validity and reliability of the simulation model. Download figure Open in new tab Figure S9: Comparative Kaplan-Meier Survival Curves for Subgroups with and without major comorbidities (Obesity, diabetes and CAD). Download figure Open in new tab Figure S10: Heat Map of Simulated vs. Observed Data Consistency: (a) shows the concordance between observed and simulated datasets across genetic, environmental, and demographic variables validating the accuracy of simulation models between real-world and simulated data distributions. (b) Expanded heat map of gene-environment correlations include additional variables like socioeconomic status or lifestyle factors highlighting multi-factorial contributors. Download figure Open in new tab Figure S11: Decision Tree Analysis of Risk Factors: how combinations of genetic and environmental factors contribute to CAD risk stratification for targeted interventions. Download figure Open in new tab Figure S12: Dynamic Visualization of PCA Over Time snapshots showing genetic risk profiles evolving risk in temporal environmental exposure over time. Download figure Open in new tab Figure S13: (a) Statistical Validation of Cluster Assignments: A silhouette plot and intra-cluster variance analysis validating the clusters formed in hierarchical heat maps. (b) Random Model Validation Using Cross-Validation Techniques: illustrate the performance of models used for predicting genetic predisposition include metrics such as mean squared error (MSE), area under the curve (AUC), or R² for each fold. Download figure Open in new tab Figure S14: Interaction Matrix for Simulated Scenarios: An interaction matrix showing the pairwise interactions between genetic variants, environmental exposures, and metabolic risk factors identifies synergistic and antagonistic interactions within simulated datasets, enriching the interpretation of complex relationships for false discovery rate (FDR) with P value significance Download figure Open in new tab Figure S15: Randomized Permutation Testing for Statistical Significance: Histograms of null distributions generated from permutation tests, alongside observed test statistics (e.g., F-statistics or chi-square values) validates the statistical significance of gene-environment interaction models by ensuring that findings are not artifacts of random associations. Download figure Open in new tab Figure S16: Model Performance Under Random Testing: comparing models performance metrics across configurations by adding the numerical values showing specificity, sensitivity, Precision, ROC AUC, F1-score and Genetic risk with CAD co-morbidities percentages. Download figure Open in new tab Figure S17: Interaction Matrix for Simulated Scenarios (a) Bubble plot shows the pairwise interactions of loading top 13 inferring high risk diseases in UAE, by differentiating gender on “X” for 65 age group. Download figure Open in new tab Figure S18: Stacked bar plots for all 13 representative diseases (Air Pollution Mortality, Obesity, Diabetes, Stroke, Myocardial Infarction, Hypertension Type II, Unintentionally Poisoning, Non Communicable Disease(NCD), Tuberculosis, Hepatitis B, Infectious Disease, Alcohol Consumption, CAD, Other) age and gender dependent subtypes in UAE. Download figure Open in new tab Figure S19: Heritability Deviation and PRS Enrichment analysis for top 7 diseases with Genetic Subtypes Download figure Open in new tab Figure S20: (a) Sensitivity Analysis for Key Simulation Parameters: showing the impact of varying key parameters (e.g., allele frequencies, exposure thresholds) on simulation outcomes. It shows outcomes across a range of parameter values for 5 years and 10 years differences, showing the impact of varying key parameters (e.g., allele frequencies, exposure thresholds) on simulation outcomes. (b) Precision recall curves for CAD severity across genetic subtypes by including 3 genes and there time interval References 1. ↵ Maggo SD , Chua EW , Chin P , Cree S , Pearson J , Doogue M , et al. A New Zealand platform to enable genetic investigation of adverse drug reactions . N Z Med J . 2017 ; 130 ( 1466 ): 62 – 9 . OpenUrl 2. ↵ Zgheib NK , Akika R , Mahfouz R , Aridi CA , Ghanem KM , Saab R , et al. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children’s Cancer Center of Lebanon . Pediatr Blood Cancer . 2016 ; 64 ( 1 ): 146 – 50 . OpenUrl PubMed 3. ↵ Huynh TV , Bergeron S . Asparaginase toxicities: Identification and management in patients with acute lymphoblastic leukemia . Clin J Oncol Nurs . 2017 ; 21 ( 5 ): 248 – 59 . OpenUrl 4. ↵ Al-Saikhan FI . Genetic risk assessment towards warfarin application: Saudi Arabia study with a potential to predict and prevent side effects . Saudi J Biol Sci . 2020 ; 27 ( 1 ): 456 – 9 . OpenUrl PubMed 5. ↵ Von der Heyde B , Emmanouilidou A , Mazzaferro E , et al. Translating GWAS-identified loci for cardiac rhythm and rate using an in vivo image- and CRISPR/Cas9-based approach . Sci Rep . 2020 ; 10 : 11831 . OpenUrl PubMed 6. ↵ Koplev S , Seldin M , Sukhavasi K , et al. A mechanistic framework for cardiometabolic and coronary artery diseases . Nat Cardiovasc Res . 2022 ; 1 : 85 – 100 . OpenUrl PubMed 7. ↵ Paixao AR , et al. Coronary artery calcium improves risk classification in younger populations . JACC Cardiovasc Imaging . 2015 ; 8 : 1285 – 93 . OpenUrl Abstract / FREE Full Text 8. ↵ Squassina A , Manchia M , Mitropoulou C , Patrinos GP . An introduction to pharmacogenomics and personalized medicine . In: Lanzer P , editor. PanVascular Medicine . Berlin, Heidelberg : Springer ; 2015 . p. 1053 – 65 . 9. ↵ Slenders L , Landsmeer LPL , Cui K , et al. Intersecting single-cell transcriptomics and genome-wide association studies identifies crucial cell populations and candidate genes for atherosclerosis . Eur Heart J Open . 2022 ; 2 : oeab043 . OpenUrl 10. ↵ Hartiala JA , Han Y , Jia Q , et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction . Eur Heart J . 2021 ; 42 : 919 – 33 . OpenUrl PubMed 11. ↵ Mosquera JV , Wong D , Auguste G , et al. Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis . bioRxiv . 2022 . doi: 10.1016/j.celrep.2023.113380 . OpenUrl CrossRef 12. ↵ Zhou W , Kanai M , Wu KHH , et al. Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease . Cell Genom . 2022 ; 2 . 13. ↵ Garrido-Martín D , Borsari B , Calvo M , et al. Identification and analysis of splicing quantitative trait loci across multiple tissues in the human genome . Nat Commun . 2021 ; 12 : 727 . OpenUrl CrossRef PubMed 14. ↵ Klarin D , Natarajan P . Clinical utility of polygenic risk scores for coronary artery disease . Nat Rev Cardiol . 2021 ; 1 – 11 . 15. ↵ Zhu D , Rashdan NA , Chapman KE , Hadoke PW , MacRae VE . A novel role for the mineralocorticoid receptor in glucocorticoid-driven vascular calcification . Vascul Pharmacol . 2016 ; 86 : 87 – 93 . OpenUrl CrossRef PubMed 16. ↵ Rentzsch P , Witten D , Cooper GM , Shendure J , Kircher M . CADD: predicting the deleteriousness of variants throughout the human genome . Nucleic Acids Res . 2019 ; 47 ( D1 ): 886 – 94 . OpenUrl 17. ↵ Aherrahrou R , Lue D , Perry RN , et al. Genetic regulation of human aortic smooth muscle cell gene expression and splicing predict causal CAD genes . Circ Res . 2023 ; 132 : 323 – 38 . OpenUrl CrossRef PubMed 18. ↵ Mountjoy E , Schmidt EM , Carmona M , et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci . Nat Genet . 2021 ; 53 : 1527 – 33 . OpenUrl CrossRef PubMed 19. ↵ Goldstein BA , Knowles JW , Salfati E , Ioannidis JP , Assimes TL . Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example . Front Genet . 2014 ; 5 : 254 . OpenUrl PubMed 20. ↵ World Health Organization . Global status report on noncommunicable diseases 2014 . Geneva : WHO ; 2014 . 21. ↵ Zhang B , Lauschke VM . Genetic variability and population diversity of the human SLCO (OATP) transporter family . Pharmacol Res . 2019 ; 139 : 550 – 9 . OpenUrl PubMed 22. ↵ Said MA , Verweij N , van der Harst P . Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study . JAMA Cardiol . 2018 ; 3 : 693 – 702 . OpenUrl CrossRef PubMed 23. ↵ Mach F , et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk . Eur Heart J . 2020 ; 41 : 111 – 88 . OpenUrl CrossRef 24. ↵ Aherrahrou R , Lue D , Civelek M . Genetic regulation of circular RNA expression in human aortic smooth muscle cells and vascular traits . HGG Adv . 2022 ; 4 ( 1 ): 100164 . OpenUrl PubMed View the discussion thread. Back to top Previous Next Posted January 20, 2025. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions Hassa Iftikhar medRxiv 2025.01.20.25320831; doi: https://doi.org/10.1101/2025.01.20.25320831 Share This Article: Copy Citation Tools Age and Gender-Dependent Comorbidities in UAE Population identifies Coronary Artery Disease with Gene-Environment Interactions Hassa Iftikhar medRxiv 2025.01.20.25320831; doi: https://doi.org/10.1101/2025.01.20.25320831 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Cardiovascular Medicine Subject Areas All Articles Addiction Medicine (568) Allergy and Immunology (863) Anesthesia (297) Cardiovascular Medicine (4421) Dentistry and Oral Medicine (443) Dermatology (382) Emergency Medicine (606) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1507) Epidemiology (15212) Forensic Medicine (30) Gastroenterology (1121) Genetic and Genomic Medicine (6581) Geriatric Medicine (667) Health Economics (996) Health Informatics (4520) Health Policy (1366) Health Systems and Quality Improvement (1611) Hematology (539) HIV/AIDS (1264) Infectious Diseases (except HIV/AIDS) (15906) Intensive Care and Critical Care Medicine (1103) Medical Education (620) Medical Ethics (144) Nephrology (667) Neurology (6580) Nursing (345) Nutrition (998) Obstetrics and Gynecology (1141) Occupational and Environmental Health (956) Oncology (3324) Ophthalmology (970) Orthopedics (369) Otolaryngology (420) Pain Medicine (435) Palliative Medicine (129) Pathology (663) Pediatrics (1689) Pharmacology and Therapeutics (691) Primary Care Research (710) Psychiatry and Clinical Psychology (5433) Public and Global Health (9212) Radiology and Imaging (2193) Rehabilitation Medicine and Physical Therapy (1368) Respiratory Medicine (1194) Rheumatology (593) Sexual and Reproductive Health (709) Sports Medicine (529) Surgery (709) Toxicology (99) Transplantation (288) Urology (265) (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9ff647213eddad07',t:'MTc3OTM5NDc4NQ=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();